27 October 2022
GSK provides update on ContRAst phase III programme for otilimab in the treatment of moderate to severerheumatoid arthritis GSK plc (LSE/NYSE: GSK) today provided…
Hargreaves Services plc (“Hargreaves” or the “Group”) AGM Statement Hargreaves Services plc (AIM: HSP), a diversified group delivering services to the industrial and property sectors,…
Renishaw plc Trading update 27 October 2022 Renishaw plc, the global provider of manufacturing technologies, analytical instruments and medical devices, publishes this trading update…
Continued strong business growth in a dynamic marketplace Q3 YTD OVERVIEW > Group volume growth of 6.6% (Q3: +6.2%)> Group pricing of +10.6% (Q3: +15.3%)> Taste & Nutrition: Volume…
Proposed Merger with JPM Elect plc-Heads of Terms 27 October 2022 JPMorgan Global Growth & Income plc Legal Entity Identifier: 5493007C3I0O5PJKR078 Proposed merger with JPMorgan…
Q3 2022 Interim Management Statement 27 October 2022 RESULTS FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2022 “In February we announced an ambitious new strategy. While the…
SHELL PLC3rd QUARTER 2022 UNAUDITED RESULTS …
Unilever Trading Statement – Third Quarter 2022 Another strong quarter of growth, sales guidance raised Third Quarter 2022 Nine Months 2022 (unaudited) USG…